CRO Quality Benchmarking – Phase II/III Service Providers: A Look at Small and Emerging Biopharma (2020)

Description

Clinical outsourcing needs and perceptions can vary quite a bit by company. ISR understands the desire for a deeper dive regarding the small and emerging biopharma landscape. ISR’s CRO Quality Benchmarking – Phase II/III Service Providers: A Look at Small and Emerging Biopharma (2020) report does just that. This research will help small and emerging biopharma companies make more informed CRO selection decisions. These findings will also help CROs optimize operational and marketing strategies to better accommodate this segment. The degree of detail provided in this report — straight from small and emerging biopharma customers — on CRO awareness, familiarity, reported use, and preference along with perceived leadership, cost perceptions and CRO selection drivers offers a bird’s eye view into this segment.

This report was compiled with the small and emerging biopharma company in mind, and various comparisons are made to the larger Phase II/III outsourcing audience.

CRO Quality Benchmarking – Phase II/III Service Providers: A Look at Small and Emerging Biopharma (2020)

Small & Emerging Sponsors:

  • Make a more educated purchase of CRO services by understanding which providers best fit your company’s needs
  • Uncover which CRO attributes drive outsourcing selection for Phase II/III clinical trials as well as which CRO attributes have gained importance over the past 12 months among industry peers
  • Understand overall CRO customer loyalty via ratings of customer satisfaction, willingness to recommend, and likelihood to use again

Service Providers:

  • Understand your company’s market awareness and positioning, and use this information to develop targeted messaging to small and emerging biopharma companies
  • Gain insight into small and emerging biopharma preferences and practices with respect to CRO selection and CRO outsourcing preferences
  • Service Provider Selection Process
  • Service Provider Perceptions and Interactions
  • Study Data
  • Demographics

ISR understands that you’re looking for confidence in your market research. With ISR, you’ll consistently receive

  • Focused Domain Expertise — We’ve operated in pharmaceuticals for over 15 years and because it’s our sole focus, our domain expertise brings value to the work that “generalist” researchers can’t deliver.
  • Genuine Research Expertise — Our market research experience has developed over 20 years in many dynamic industries.  We capture appropriate sample sizes, given the research objectives, and we use appropriately sophisticated statistics to uncover everything that’s real and to give you confidence in your decisions. Read our Six Questions to Ask About Your Market Research to learn more about why our industry expertise sets us apart.
  • Transparency — If you’re like many, you’ve been disappointed more than once by research providers who fail to live up to their promises, providing you with their “professional judgment” in place of sound data; and suspect contacts instead of real decision-makers. We deliver the beliefs, attitudes, and intentions of people who matter – and we’ll prove it by showing you the titles of your respondents.

For additional questions about any of ISR’s reports or custom research services, please contact us at info@ISRreports.com.

For Pharma Project Managers - Preview page from CRO Quality Benchmarking Phase II/III Service Providers: Small and Emerging

Service Provider Selection Process

Primary Section Takeaways
Preferred Provider Agreements
Number of Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants

Select Respondent Comments

Service Provider Perceptions and Interactions

Primary Section Takeaways
Phase II/III Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table
CRO Loyalty

Respondent Comments

Study Data

Phase II/III Leaders, Unprompted
Phase II/III Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants

Outside Consultant Assistance

Demographics

Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age

Additional information

License

, ,